InvestLog
SABS SAB Biotherapeutics, Inc. logo

SABS SAB Biotherapeutics, Inc.

Healthcare
$3.90+2.36%ClosedMarket Cap: $37.3M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

48

13F Shares

36,342,111

Ownership %

340.9%

New Positions

21

Increased Positions

32

Closed Positions

7

Reduced Positions

4

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
SURISimplify Propel Opportunities ETF187,2301.06%
AVSCAvantis U.S. Small Cap Equity ETF37,4550.01%
VIEIX76,4870.00%
VXF76,4870.00%
VITPX27,8550.00%
VITNX27,8550.00%
VEXAX76,4870.00%
VEMPX76,4870.00%
VITSX1,640,7930.00%
VTSAX1,640,7930.00%
VSMPX1,640,7930.00%
VTIVanguard Total Stock Market ETF1,640,7930.00%
VBIAX26,1080.00%
VBINX26,1080.00%
VBAIX26,1080.00%